Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by reeJoeyon Mar 13, 2020 6:00pm

39 Views

Post# 30806355

RE:RE:CDC: Up to 1.7 million Americans die

Of coarse they die. Maybe some day you too will be lucky enough to die in your old age--it will mean you will have made it to that point--many don't. But they don't die at this accelerated Coronavirus rate. I really do wonder about the intelligence of many on this board. Seem to even lack common sense. Dare I say even dumb?

Bullboard Posts

5 steps to mastering risk management in the stock market